ACB vs HBIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
ACB
HBIO
Investment Advisor Scores
HBIO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ACB | HBIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 109.8901 | 15.0602 | HBIO |
| PEG Ratio | 0 | 1.3059 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -8.8% | 11.1% | HBIO |
| Earnings Growth | -94.7% | -80.3% | HBIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 45.3/100 | 46.5/100 | HBIO |
| Profit Margin | -38.2% | -11.9% | HBIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ACB
NeutralMixed signals - no dominant trend phase, RSI 44
HBIO
MarkupPrice above SMA50, rising 50-day trend (11.7% over 20 days), RSI 62
Fundamentals Snapshot
| Metric | ACB | HBIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -660.0 | 13.2 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.1% |
| Gross Margin | 0.4% | 0.6% |
| Operating Margin | -0.1% | 0.0% |
| EPS | -0.61 | -2.31 |
| Dividend Yield | — | — |